ScholarIQanswers from OpenAlex
Vascular Anomalies and Treatments
TopicLeading institutions, researchers & key papers
Vascular Anomalies and Treatments is a topic indexed in ScholarIQ from OpenAlex.
What is known about Vascular Anomalies and Treatments?
ScholarIQrecord summary
This cluster of papers focuses on the diagnosis and management of hereditary hemorrhagic telangiectasia (HHT), a genetic disorder characterized by vascular malformations. It covers topics such as genetics, pulmonary arteriovenous malformations, embolization, epistaxis, liver involvement, SMAD4 mutations, and vascular anomalies.
How many works does Vascular Anomalies and Treatments have?
ScholarIQindexed works
Vascular Anomalies and Treatments has 94 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
What is the OpenAlex record for Vascular Anomalies and Treatments?
ScholarIQopenalex
The OpenAlex for Vascular Anomalies and Treatments is on the source record.
What are the most-cited papers on Vascular Anomalies and Treatments?
ScholarIQmost cited works
Endoglin, a TGF-β binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia type 1
Kimberly A. McAllister, K.M. Grogg, David W. Johnson, Carol J. Gallione, Melanie A. Baldwin, Charles E. Jackson, E.A. Helmbold, Dorene S. Markel, Wendy McKinnon, J. Murrel, Mary Kay McCormick, M. A. Pericak‐Vance, Peter Heutink, Ben A. Oostra, T. Haitjema, C.J.J. Westerman, Mary Porteous, Alan E. Guttmacher, Michelle Letarte, Douglas A. Marchuk
Mutations in the activin receptor–like kinase 1 gene in hereditary haemorrhagic telangiectasia type 2
David W. Johnson, Jonathan Berg, Melanie A. Baldwin, Carol J. Gallione, Ivonne Marondel, Sang-Heon Yoon, Timothy T. Stenzel, Marcy C. Speer, M. A. Pericak‐Vance, Austin G. Diamond, Alan E. Guttmacher, Charles E. Jackson, Liliana Attisano, Raju Kucherlapati, Mary Porteous, Douglas A. Marchuk
International guidelines for the diagnosis and management of hereditary haemorrhagic telangiectasia
Marie E. Faughnan, Valerie A. Palda, Guadalupe García–Tsao, Urban W. Geisthoff, Jamie McDonald, Deborah D. Proctor, John C. Spears, Dale Brown, Elisabetta Buscarini, Mark S. Chesnutt, Vincent Cottin, Arupa Ganguly, James R. Gossage, Alan E. Guttmacher, Robert H. Hyland, Shelley Kennedy, Joshua R. Korzenik, Johannes J. Mager, Augustin Ozanne, Jay F. Piccirillo, Daniel Picus, Henri Plauchu, Mary Porteous, Reed E. Pyeritz, Douglas A. Ross, Carlo Sabbà, Karen L. Swanson, P. B. Terry, M. Christopher Wallace, C. J. J. Westermann, Robert I. White, Lawrence H. Young, Roberto Zarrabeitia
Pulmonary Arteriovenous Malformations in Hereditary Hemorrhagic Telangiectasia
Vincent Cottin, Thierry Chinet, A. Lavolé, R. Corre, Éric Marchand, Martine Reynaud‐Gaubert, Henri Plauchu, Jean-François Cordier
Clinical Practice Guideline: Nosebleed (Epistaxis)
David E. Tunkel, Samantha Anne, Spencer C. Payne, Stacey L. Ishman, Richard M. Rosenfeld, Peter J. Abramson, Jacqueline D. Alikhaani, Margo McKenna Benoit, Rachel S. Bercovitz, Michael D. Brown, Boris Chernobilsky, David Feldstein, Jesse M. Hackell, Eric H. Holbrook, Sarah M. Holdsworth, Kenneth W. Lin, Meredith Merz Lind, David M. Poetker, Charles A. Riley, John S. Schneider, Michael D. Seidman, Venu Vadlamudi, Tulio A. Valdez, Lorraine C. Nnacheta, Taskin M. Monjur
Where is Vascular Anomalies and Treatments research published, and who funds it?
ScholarIQvenues & funding sources
TOP JOURNALS
TOP FUNDERS
National Science Foundation—
NIH—
Wellcome Trust—
European Research Council—
Funder breakdown is a member featureSign up free to unlock
How much of the research on Vascular Anomalies and Treatments is open access?
ScholarIQopen access share
40%OPEN ACCESS